FBIO
Income statement / Annual
Last year (2024), Fortress Biotech, Inc.'s total revenue was $57.68 M,
a decrease of 31.76% from the previous year.
In 2024, Fortress Biotech, Inc.'s net income was -$46.00 M.
See Fortress Biotech, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2024
|
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
| Period Ended |
12/31/2024 |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
| Operating Revenue |
$57.68 M |
$84.51 M |
$75.74 M |
$68.79 M |
$45.60 M |
$36.63 M |
$26.88 M |
$187.58 M |
$16.48 M |
$863,000.00 |
| Cost of Revenue |
$20.88 M
|
$26.66 M
|
$30.78 M
|
$32.08 M
|
$14.59 M
|
$10.53 M
|
$6.13 M
|
$161.20 M
|
$11.35 M
|
$0.00
|
| Gross Profit |
$36.80 M
|
$57.85 M
|
$44.97 M
|
$36.71 M
|
$31.01 M
|
$26.10 M
|
$20.76 M
|
$26.38 M
|
$5.13 M
|
$863,000.00
|
| Gross Profit Ratio |
0.64
|
0.68
|
0.59
|
0.53
|
0.68
|
0.71
|
0.77
|
0.14
|
0.31
|
1
|
| Research and Development Expenses |
$56.88 M
|
$106.07 M
|
$134.88 M
|
$128.87 M
|
$64.11 M
|
$81.33 M
|
$87.38 M
|
$52.49 M
|
$35.13 M
|
$29.81 M
|
| General & Administrative Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$55.59 M
|
$53.37 M
|
$73.02 M
|
$35.16 M
|
$21.58 M
|
| Selling & Marketing Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$155.19 M
|
$10.41 M
|
$0.00
|
| Selling, General & Administrative Expenses |
$87.73 M
|
$94.12 M
|
$113.66 M
|
$86.84 M
|
$61.17 M
|
$55.59 M
|
$53.37 M
|
$73.02 M
|
$35.16 M
|
$21.58 M
|
| Other Expenses |
$2.56 M
|
$0.00
|
-$1.30 M
|
$25.17 M
|
$2.83 M
|
$6.09 M
|
$68,000.00
|
-$234,000.00
|
-$9.87 M
|
$11.41 M
|
| Operating Expenses |
$147.18 M
|
$200.20 M
|
$247.23 M
|
$215.71 M
|
$125.28 M
|
$136.92 M
|
$140.75 M
|
$127.59 M
|
$70.84 M
|
$51.39 M
|
| Cost And Expenses |
$168.05 M
|
$226.86 M
|
$278.00 M
|
$247.79 M
|
$139.87 M
|
$147.45 M
|
$146.88 M
|
$288.79 M
|
$82.19 M
|
$51.39 M
|
| Interest Income |
$2.68 M
|
$3.00 M
|
$1.40 M
|
$649,000.00
|
$1.52 M
|
$2.56 M
|
$1.10 M
|
$819,000.00
|
$298,000.00
|
$245,000.00
|
| Interest Expense |
$11.59 M
|
$11.92 M
|
$13.64 M
|
$15.31 M
|
$9.70 M
|
$11.85 M
|
$10.34 M
|
$5.86 M
|
$3.69 M
|
$1.48 M
|
| Depreciation & Amortization |
$4.46 M
|
$8.08 M
|
$9.35 M
|
$6.79 M
|
$5.33 M
|
$4.65 M
|
$2.06 M
|
$1.26 M
|
$728,000.00
|
$26,000.00
|
| EBITDA |
-$104.49 M |
-$133.64 M |
-$190.47 M |
-$142.25 M |
-$87.82 M |
-$85.16 M |
-$118.40 M |
-$88.57 M |
-$66.87 M |
-$52.37 M |
| EBITDA Ratio |
-1.81
|
-1.58
|
-2.51
|
-2.07
|
-1.93
|
-2.32
|
-4.4
|
-0.47
|
-4.06
|
-60.69
|
| Operating Income Ratio |
-1.91
|
-1.68
|
-2.67
|
-2.6
|
-2.07
|
-3.03
|
-4.46
|
-0.54
|
-3.99
|
-58.55
|
| Total Other Income/Expenses Net |
-$10.16 M
|
-$11.29 M
|
-$9.90 M
|
$24.19 M
|
-$8.58 M
|
$9.16 M
|
-$10.80 M
|
-$7.72 M
|
-$5.58 M
|
-$3.35 M
|
| Income Before Tax |
-$120.54 M
|
-$153.63 M
|
-$213.46 M
|
-$164.35 M
|
-$102.85 M
|
-$101.66 M
|
-$130.80 M
|
-$98.32 M
|
-$71.29 M
|
-$53.88 M
|
| Income Before Tax Ratio |
-2.09
|
-1.82
|
-2.82
|
-2.39
|
-2.26
|
-2.78
|
-4.87
|
-0.52
|
-4.33
|
-62.44
|
| Income Tax Expense |
$312,000.00
|
$521,000.00
|
$449,000.00
|
$473,000.00
|
$136,000.00
|
-$49.85 M
|
-$463,000.00
|
$1.51 M
|
-$12.51 M
|
-$4.00 M
|
| Net Income |
-$46.00 M
|
-$60.64 M
|
-$213.91 M
|
-$164.83 M
|
-$102.99 M
|
-$51.81 M
|
-$84.15 M
|
-$66.88 M
|
-$55.10 M
|
-$48.43 M
|
| Net Income Ratio |
-0.8
|
-0.72
|
-2.82
|
-2.4
|
-2.26
|
-1.41
|
-3.13
|
-0.36
|
-3.34
|
-56.12
|
| EPS |
-2.21 |
-8.47 |
-36.1 |
-30.26 |
-21.45 |
-14.2 |
-29.04 |
-24.08 |
-20.68 |
-18.56 |
| EPS Diluted |
-2.21 |
-8.47 |
-36.1 |
-30.26 |
-21.45 |
-14.2 |
-29.04 |
-24.08 |
-20.68 |
-18.56 |
| Weighted Average Shares Out |
$20.78 M
|
$8.11 M
|
$5.92 M
|
$5.45 M
|
$4.80 M
|
$3.65 M
|
$2.90 M
|
$2.78 M
|
$2.66 M
|
$2.61 M
|
| Weighted Average Shares Out Diluted |
$20.78 M
|
$8.11 M
|
$5.92 M
|
$5.45 M
|
$4.80 M
|
$3.65 M
|
$2.90 M
|
$2.78 M
|
$2.66 M
|
$2.61 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
